Mx. Shen et al., CANNABINOID RECEPTOR AGONISTS INHIBIT GLUTAMATERGIC SYNAPTIC TRANSMISSION IN RAT HIPPOCAMPAL CULTURES, The Journal of neuroscience, 16(14), 1996, pp. 4322-4334
Activation of cannabinoid receptors inhibits voltage-gated Ca2+ channe
ls and activates K+ channels, reminiscent of other G-protein-coupled s
ignaling pathways that produce presynaptic inhibition. We tested canna
binoid receptor agonists for effects on excitatory neurotransmission b
etween cultured rat hippocampal neurons. Reducing the extracellular Mg
2+ concentration to 0.1 mM elicited repetitive, transient increases in
intracellular Ca2+ concentration ([Ca2+](i) spikes) that resulted fro
m bursts of action potentials, as measured by combined whole-cell curr
ent clamp and indo-1-based microfluorimetry. Pharmacological character
ization indicated that the [Ca2+](i) spikes required glutamatergic syn
aptic transmission. Cannabinoid receptor ligands inhibited stereoselec
tively the frequency of [Ca2+](i) spiking in the rank order of potency
: CP 54,939 > CP 55,940 > Win 55,212-2 > anandamide, with EC(50) value
s of 0.36, 1.2, 2.7, and 71 nM, respectively. CP 55,940 was potent, bu
t not efficacious, and reversed the inhibition produced by Win55,212-2
, indicating that it is a partial agonist. Inhibition of [Ca2+](i) spi
king by Win 55,212-2 was prevented by treatment of cultures with activ
e, but not heat-treated, pertussis toxin. Win 55,212-2 (100 nM) inhibi
ted stereoselectively CNQX-sensitive excitatory postsynaptic currents
(EPSCs) elicited by presynaptic stimulation with an extracellular elec
trode, but did not affect the presynaptic action potential or currents
elicited by direct application of kainate. Consistent with a presynap
tic site of action, Win 55,212-2 increased both the number of response
failures and the coefficient of variation of the evoked EPSCs. In con
trast, cannabimimetics did not affect bicuculline-sensitive inhibitory
postsynaptic currents. Thus, activation of cannabinoid receptors inhi
bits the presynaptic release of glutamate via an inhibitory G-protein.